First Time Loading...

Merus NV
NASDAQ:MRUS

Watchlist Manager
Merus NV Logo
Merus NV
NASDAQ:MRUS
Watchlist
Price: 47.02 USD 4.7% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

MRUS Price Targets Summary
Merus NV

Wall Street analysts forecast MRUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRUS is 62.05 USD with a low forecast of 52.52 USD and a high forecast of 72.45 USD.

MRUS Lowest Forecast
Wall Street Target
52.52 USD
12% Upside
MRUS Average Forecast
Wall Street Target
62.05 USD
32% Upside
MRUS Highest Forecast
Wall Street Target
72.45 USD
54% Upside
Lowest
Price Target
52.52 USD
12% Upside
Average
Price Target
62.05 USD
32% Upside
Highest
Price Target
72.45 USD
54% Upside
Merus NV Competitors:
Price Targets
300653
Yantai Zhenghai Bio-Tech Co Ltd
41% Upside
EXEL
Exelixis Inc
24% Upside
BONEX
Bonesupport Holding AB
24% Upside
CDNA
CareDx Inc
38% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
41% Upside
EXEL
Exelixis Inc
24% Upside
BONEX
Bonesupport Holding AB
24% Upside
CDNA
CareDx Inc
38% Upside
E
1952
Everest Medicines Ltd
1% Upside
ASND
Ascendis Pharma A/S
30% Upside
ALGEN
Genoway SA
62% Upside
Y
301301
Yili Chuanning Biotechnology Co Ltd
20% Downside

Revenue
Forecast

Revenue Estimate
Merus NV

For the last 8 years the compound annual growth rate for Merus NV's revenue is 45%. The projected CAGR for the next 3 years is 41%.

45%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Merus NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Merus NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
What are analyst estimates?

See Also

Summary
MRUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRUS stock valuation using valuation multiples.
Wall Street Estimates
MRUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRUS's stock price target?
Price Target
62.05 USD

According to Wall Street analysts, the average 1-year price target for MRUS is 62.05 USD with a low forecast of 52.52 USD and a high forecast of 72.45 USD.

What is Merus NV's Revenue forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Merus NV's revenue is 45%. The projected CAGR for the next 3 years is 41%.

ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.